Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization

European Journal of Cell Biology

Volumn 74, Issue 4, 1997, Pages 376-384

  Logeart, Delphine ^a   Prigent Richard, Sandrine ^a   Jozefonvicz, Jacqueline ^a   Letourneur, Didier ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Fucan; Growth inhibition; Heparin; Internalization; Vascular smooth muscle cells

Indexed keywords

CELL DNA; CHONDROITIN SULFATE; DEXTRAN; FLUORESCEIN DERIVATIVE; HEPARIN; POLYSACCHARIDE SULFATE;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL COUNT; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOFLUOROMETRY; DISSOCIATION CONSTANT; DNA SYNTHESIS; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG BINDING; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; SEAWEED; VASCULAR SMOOTH MUSCLE;

EID: 0030698667     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Adams, J. G., L. J. Humphrey, X. Zhang, D. Silver: Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies? J. Vasc. Surg. 21, 247-254 (1995).
2. Au, Y. P. T., R. D. Kenagy, M. M. Clowes, A. W. Clowes: Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis 23, 177-182 (1993).
3. Au, Y. P. T., G. Dobrowolska, D. R. Morris, A. W. Clowes: Heparin decreases activator-1 binding to DNA in part by posttranscriptional modification of Jun B. Circ. Res. 75, 15-22 (1994).
4. Avramoglou, T., J. Jozefonvicz: Derivatized dextran inhibition of smooth muscle cell proliferation. J. Biomater. Sci. Polym. Ed. 3, 149-154 (1991).
5. Barzu, T., A. Desmouliere, J. M. Herbert, M. Level, J. P. Herault, M. Petitou, J. C. Lormeau, G. Gabbiani, M. Pascal: O-acetylated heparin derivatives with low anticoagulant activity decrease proliferation and increase α-smooth muscle actin expression in cultured arterial smooth muscle cells. Eur. J. Pharmacol. 219, 225-233 (1992).
6. Barzu, T., M. Pascal, M. Maman, C. Roque, F. Lafont, A. Rousselet: Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: Comparison between heparin-sensitive and heparin-resistant cultures. J. Cell. Physiol. 167, 8-21 (1996).
7. Benitz, W. E., R. T. Kelley, C. M. Anderson, D. E. Lorant, M. Bernfield: Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation. Am. J. Respir. Cell Mol. Biol. 2, 13-24 (1990).
8. Blakeslee, D., M. G. Baines: Immunofluorescence using dichlorotriazinyl-aminofluorescein (DTAF). Preparation and fractionation of labelled IgG. J. Immunol. Methods 13, 305-320 (1976).
9. Blondin, C., A. M. Fischer, C. Boisson-Vidal, M. D. Kazatchkine, J. Jozefonvicz: Inhibition of complement activation by natural sulfated polysaccharides (fucans) from brown seaweed. Molec. Immunol. 31, 247-253 (1994).
10. Bolton, A. E., W. M. Hunter: The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem. J. 133, 529-539 (1973).
11. Bourdillon, M. C., J. P. Boissel, B. Crouset, A. Perrin: Primary culture of rat aortic media: A growth stop phenomenon different from contact inhibition. Biomedicine 25, 263-267 (1976).
12. Brack, M. J., S. Ray, A. Chauhan, J. Fox, P. J. B. Hubner, P. Schofield, A. Harley, A. H. Gershlick: The subcutaneous heparin and angioplasty restenosis prevention (SHARP) Trial. J. Am. Coll. Cardiol. 26, 947-954 (1995).
13. Busch, S. J., G. A. Martin, R. L. Barnhart, M. Mano, A. D. Cardin, R. L. Jackson: Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription. J. Cell Biol. 116, 31-42 (1992).
14. Burton-Wurster, N., D.-W. Zhang, G. Lust: Accumulation of fibronectin in cartilage explants cultured with TGFβ 1 and fucoidan. Arch. Biochem. Biophys. 316, 452-460 (1995).
15. Cadroy, Y., J. Amrial, H. Raynaud, P. Brunel, A. Mazaleyrat, M. Sauer, P. Sié: Evolution of antibodies anti-PF4/heparin in a patient with a history of heparin-induced thrombocytopenia reexposed to heparin. Thromb. Haemostasis 72, 783-784 (1994).
16. Castellot, J. J., M. L. Addonizio, R. D. Rosenberg, M. J. Karnovsky: Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J. Cell Biol. 90, 372-379 (1981).
17. Castellot, J. J., L. V. Favreau, M. J. Karnovsky, R. D. Rosenberg: Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. A possible role of a platelet endoglycosidase. J. Biol. Chem. 257, 11256-11260 (1982).
18. Castellot, J. J., D. L. Beeler, R. D. Rosenberg, M. J. Karnovsky: Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells. J. Cell. Physiol. 120, 315-320 (1984).
19. Castellot, J. J., D. L. Cochran, M. J. Karnovsky: Effects of heparin on vascular smooth muscle cells. I: Cell metabolism. J. Cell. Physiol. 124, 21-28 (1985).
20. Castellot, J. J., K. Wong, B. Herman, R. L. Hoover, D. F. Albertini, T. C. Wright, B. L. Caleb, M. J. Karnovsky: Binding and internalization of heparin by vascular smooth muscle cells. J. Cell. Physiol. 124, 13-20 (1985).
21. Castellot, J. J., J. Choay, J. C. Lormeau, M. Petitou, E. Sache, M. J. Karnovsky: Structural determinants of the capacity of heparin to inhibit the proliferation of SMCs. II: Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group. J. Cell Biol. 102, 1979-1984 (1986).
22. Castellot, J. J., M. J. Karnovsky: Heparin and the regulation of growth in the vascular wall. In: J. H. Campbell, G. R. Campbell (eds.): Vascular smooth muscle in culture. pp. 93-115. CRC Press. Boca Raton, Florida 1987.
23. Castellot, J. J., L. A. Pukac, B. L. Caleb, T. C. Wright, M. J. Karnovsky: Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J. Cell Biol. 109, 3147-3155 (1989).
24. Clowes, A. W., M. J. Karnovsky: Suppression by heparin of smooth muscle cell proliferation in the injured arteries. Nature 265, 625-636 (1977).
25. Clowes, A. W., M. M. Clowes: Kinetics of cellular proliferation after arterial injury. II: Inhibition of smooth muscle growth by heparin. Lab. Invest. 52, 611-616 (1985).
26. Clowes, A. W., M. M. Clowes: Kinetics of cellular proliferation after arterial injury. IV: Heparin inhibits rat smooth muscle mitogenesis and migration. Circ. Res. 58, 839-845 (1986).
27. Clowes, A. W.: Regulation of smooth muscle cell function by heparin. J. Vasc. Surg. 15, 911-913 (1992).
28. Colliec, S., A.-M. Fischer, J. Tapon-Bretaudiere, C. Boisson, P. Durand, J. Jozefonvicz: Anticoagulant properties of a fucoidan fraction. Thromb. Res. 64, 143-154 (1991).
29. Colliec, S., C. Boisson-Vidal, J. Jozefonvicz: A low molecular weight fucoidan fraction from the brown seaweed pelvetia canaliculata. Phytochemistry 35, 697-700 (1994).
30. Doctor, V. M., C. Hill, G. J. Jackson: Effect of fucoidan during activation of human plasminogen. Thromb. Res. 79, 237-247 (1995).
31. Fager, G., G. Camejo, G. Bondjers: Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I: Evidence for reversible binding and inactivation of the platelet-derived growth factor by heparin. In Vitro Cell. Dev. Biol. 28A, 168-175 (1992).
32. Fedarko, N. S., H. E. Conrad: A unique heparin sulfate proteoglycan in the nuclei of hepatocytes. Structural changes with the growth state of the cells. J. Cell Biol. 102, 587-599 (1986).
33. Geary, R. L., N. Koyama, T. W. Wang, S. Vergel, A. W. Clowes: Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation. Circulation 91, 2972-2981 (1995).
34. Grauffel, V., B. Kloareg, S. Mabeau, P. Durand, J. Jozefonvicz: New natural polysaccharides with potent antithrombic activity: Fucans from brown algae. Biomaterials 10, 363-367 (1989).
35. Guyton, J. R., R. D. Rosenberg, A. W. Clowes, M. J. Karnovsky: Inhibition of rat arterial smooth muscle cell proliferation by heparin. In vivo studies with anticoagulant and nonanticoagulant heparin. Circ. Res. 46, 625-634 (1980).
36. Hämmerle, H., E. Betz, D. Herr: Human endothelial cells are stimulated and vascular smooth muscle cells are inhibited in their proliferation and migration by heparins. Vasa 20, 207-215 (1991).
37. Hatton, M. W. C., L. R. Berry, H. Kaur, A. Koj, E. Regoeczi: Chromatography of heparin on sepharose-lysine. Molecular size fractionation and its relevance to thrombin and antithrombin III binding. J. Can. Biochem. 57, 1183-1190 (1979).
38. Hatton, M. W. C., L. R. Berry, R. M. Achovich, E. Regoeczi: Tritiation of commercial heparins by reaction with NaB[3H]4: Chemical analysis and biological properties of the product. Anal. Biochem. 106, 417-426 (1980).
39. Herrmann, H., S. Okada, E. Hozakowska, R. F. LeVeen, M. A. Golden, J. E. Tomaszewski, P. Weisz, E. S. Barnathan: Inhibition of smooth muscle cell proliferation and experimental angioplasty restenosis by β-cyclodextrin tetradecasulfate. Arterioscler. Thromb. 13, 924-931 (1993).
40. Hoover, R. L., R. D. Rosenberg, W. Haering, M. J. Karnovsky: Inhibition of rat arterial smooth muscle cell proliferation by heparin. II: In vitro studies. Circ. Res. 47, 578-583 (1980).
41. Ishihara, M., N. S. Fedarko, H. E. Conrad: Transport of heparan sulfate into the nuclei of hepatocytes. J. Biol. Chem. 261, 13575-13580 (1986).
42. Jackson, R. L., S. J. Busch, A. D. Cardin: Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71, 481-539 (1991).
43. Kohler, T. R., T. Kirkman, A. W. Clowes: Effect of heparin on adaptation of vein grafts to arterial circulation. Arteriosclerosis 9, 523-528 (1989).
44. Letourneur, D., D. Logeart, T. Avramoglou, J. Jozefonvicz: Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: The model of derivatized dextrans as heparin-like polymers. J. Biomater. Sci. Polym. Ed. 4, 431-444 (1993).
45. Letourneur, D., J. Champion, F. Slaoui, J. Jozefonvicz: In vitro stimulation of human endothelial cells by derivatized dextrans. In Vitro Cell. Dev. Biol. 29, 67-72 (1993).
46. Letourneur, D., B. L. Caleb, J. J. Castellot: Heparin binding, internalization and metabolism in vascular smooth muscle cells. I: Upregulation of heparin binding correlates with antiproliferative activity. J. Cell. Physiol. 165, 676-686 (1995).
47. Letourneur, D., B. L. Caleb, J. J. Castellot: Heparin binding, internalization and metabolism in vascular smooth muscle cells. II: Degradation and secretion in sensitive and resistant cells. J. Cell. Physiol. 165, 687-695 (1995).
48. Lindner, V., N. E. Olson, A. W. Clowes, M. A. Reidy: Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J. Clin. Invest. 90, 2044-2049 (1992).
49. Logeart, D., T. Avramoglou, J. Jozefonvicz: Functional dextrans inhibit rat arterial smooth muscle cell growth in vitro. Colloids and Surfaces B: Biointerfaces. 2, 315-322 (1994).
50. Logeart, D., D. Letourneur, J. Jozefonvicz, P. Kern: Collagen synthesis by smooth muscle cells in the presence of antiproliferative polysaccharides. J. Biomed. Mater. Res. 30, 501-508 (1996).
51. Logeart, D., S. Prigent-Richard, C. Boisson-Vidal, F. Chaubet, P. Durand, J. Jozefonvicz, D. Letourneur: Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect. Eur. J. Cell Biol. 74, 385-390 (1997).
52. McCaffrey, T. A., D. J. Falcone, W. Borth, C. F. Brayton, B. B. Weksler: Fucoidan is a non-anticoagulant inhibitor of intimal hyperplasia. Biochem. Biophys. Res. Commun. 184, 773-781 (1992).
53. Nardella, A., F. Chaubet, C. Boisson-Vidal, C. Blondin, P. Durand, J. Jozefonvicz: Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum. Carbohydr. Res. 298, 201-208 (1996).
54. Pukac, L. A., G. M. Hirsch, J.-C. Lormeau, M. Petitou, J. Choay, M. J. Karnovsky: Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo. Am. J. Pathol. 139, 1501-1509 (1991).
55. Reilly, C. F., L. M. S. Fritze, R. D. Rosenberg: Heparin inhibition of smooth muscle cell proliferation: a cellular site of action. J. Cell. Physiol. 129, 11-19 (1986).
56. Reilly, C. F., M. S. Kindy, K. E. Brown, R. D. Rosenberg, G. E. Sonenshein: Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J. Biol. Chem. 264, 6990-6995 (1989).
57. Reilly, C. F., T. Fujita, R. C. McFall, I. I. Stabilito, W. S. Eng, R. G. Johnson: Pharmacological and mechanistic aspects concerning the use of heparin and β-cyclodextrin tetradecasulfate for the treatment of vascular restenosis. Drug Dev. Res. 29, 137-147 (1993).
58. Resink, T. J., T. Scott-Burden, U. Baur, M. Bürgin, F. R. Bühler: Decreased susceptibility of cultured smooth muscle cells from SHR rats to growth inhibition by heparin. J. Cell. Physiol. 138, 137-144 (1989).
59. Ross, R.: The pathogenesis of atherosclerosis - An update. N. Engl. J. Med. 314, 488-500 (1986).
60. Ross, R.: Cell biology of atherosclerosis. Annu. Rev. Physiol. 57, 791-804 (1995).
61. Schmidt, A., G. Lemming, K. Yoshida, E. Buddecke: Molecular organization and antiproliferative domains of arterial tissue heparan sulfate. Eur. J. Cell Biol. 59, 322-328 (1992).
62. Schwartz, S. M., L. Liaw: Growth control and morphogenesis in the development and pathology of arteries. J. Cardiovasc. Pharmacol. 21, 31-49 (1993).
63. Sing, J. P., T. R. Wiernicki, S. K. Gupta: Role of serine/threonine kinase casein-II in vascular smooth muscle cell proliferation and inhibition by heparin. Drug Dev. Res. 29, 129-136 (1993).
64. Skalli, O., P. Ropraz, A. Trzeciak, G. Benzonana, D. Gillessen, G. Gabbiani: A monoclonal antibody against α-smooth muscle actin. A new probe for smooth muscle differentiation. J. Cell Biol. 103, 2787-2796 (1986).
65. Vischer, P., E. Buddecke: Different action of heparin and fucoidan on arterial smooth muscle cell proliferation and thrombospondin and fibronectin metabolism. Eur. J. Cell Biol. 56, 407-414 (1991).
66. Watanabe, J., H. Muranishi, H. Yuasa: Uptake of fractionated 3H-heparin by rat parenchymal hepatocytes in primary culture. Biol. Pharm. Bull. 16, 497-500 (1993).